drug repurposing entails the identification of existing therapeutics originally developed for other medical purposes and reusing them for the treatment of cancer. This could be of tremendous benefit for glioblastoma patients, since repurposed compounds may be implemented into the clinic much faster, because of their known safety profiles. Moreover, repurposed treatments are considered as highly cost-effective therapeutic options, compared to most newly developed drugs.